2024-517381-42-00CompletedPhase 1
Safety of TEG001 in patients with r/r AML/high-risk MDS or r/r MM
Source: EU CTIS (euclinicaltrials.eu) · Last updated 14 Oct 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- First submitted
- 25 Sept 2024
- Start date
- 14 Oct 2024
- Lead sponsor
- Universitair Medisch Centrum Utrecht
- EU CT number
- 2024-517381-42-00
- EudraCT number
- 2016-003164-39
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 18
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitair Medisch Centrum Utrecht | Utrecht | Netherlands | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.